Georgina Cheng
Papers
2
Total Citations
150
H-Index
2
About
Dr. Georgina Cheng is a leading gynecologic oncologist whose research focuses on optimizing surgical and thromboprophylactic care for women with gynecologic malignancies. Her most impactful work, a 2020 study with 133 citations, rigorously evaluated the safety and efficacy of apixaban versus enoxaparin for preventing venous thromboembolism after surgery for gynecologic cancer. This research directly addresses a critical clinical challenge—the high cost and low adherence associated with the standard 28-day enoxaparin regimen—by providing evidence for a more patient-friendly oral alternative. Dr. Cheng has also made notable contributions to the field of minimally invasive surgery, investigating the implications of robotic techniques for endometrial cancer. Her 2014 study on lymphovascular space invasion (LVSI) and the use of uterine manipulators in robotic surgery, cited 17 times, helps clarify safety concerns surrounding these advanced approaches. By tackling pressing questions about postoperative complications and surgical innovation, Dr. Cheng’s work has a tangible impact on clinical guidelines and patient outcomes, establishing her as a key voice in advancing both the safety and quality of life for women facing gynecologic cancers.
Research Focus
Key Achievements
Top Papers
- 1
- 2Lymphovascular Space Invasion in Robotic Surgery for Endometrial Cancer17 citations · 2014